Free Trial

The Pennant Group (NASDAQ:PNTG) Receives "Overweight" Rating from Stephens

The Pennant Group logo with Medical background

The Pennant Group (NASDAQ:PNTG - Get Free Report)'s stock had its "overweight" rating restated by stock analysts at Stephens in a report released on Tuesday,Benzinga reports. They presently have a $35.00 target price on the stock. Stephens' target price would suggest a potential upside of 23.04% from the stock's previous close.

PNTG has been the subject of several other reports. Truist Financial lifted their target price on The Pennant Group from $28.00 to $32.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. Wells Fargo & Company upped their price objective on shares of The Pennant Group from $30.00 to $31.00 and gave the company an "equal weight" rating in a report on Tuesday, June 3rd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $34.60.

View Our Latest Stock Report on PNTG

The Pennant Group Stock Performance

Shares of PNTG traded up $0.10 during midday trading on Tuesday, reaching $28.45. The stock had a trading volume of 83,810 shares, compared to its average volume of 223,705. The firm has a market cap of $980.47 million, a PE ratio of 41.83, a P/E/G ratio of 2.24 and a beta of 1.51. The firm has a 50 day simple moving average of $27.15 and a 200-day simple moving average of $26.82. The Pennant Group has a one year low of $21.18 and a one year high of $37.13. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.58.

Insider Buying and Selling

In other news, Director Joanne Stringfield sold 5,000 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the sale, the director now directly owns 30,275 shares in the company, valued at approximately $892,204.25. This represents a 14.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 5.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers increased its holdings in The Pennant Group by 6.0% in the 4th quarter. Rhumbline Advisers now owns 43,673 shares of the company's stock worth $1,158,000 after purchasing an additional 2,480 shares in the last quarter. Principal Financial Group Inc. increased its position in The Pennant Group by 10.9% during the 4th quarter. Principal Financial Group Inc. now owns 14,000 shares of the company's stock valued at $371,000 after purchasing an additional 1,374 shares during the period. Hussman Strategic Advisors Inc. bought a new position in The Pennant Group during the 4th quarter worth approximately $1,114,000. Van Berkom & Associates Inc. raised its holdings in The Pennant Group by 2,635.6% during the 4th quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company's stock worth $58,297,000 after purchasing an additional 2,117,859 shares during the last quarter. Finally, Navellier & Associates Inc. lifted its position in shares of The Pennant Group by 86.3% in the 4th quarter. Navellier & Associates Inc. now owns 45,627 shares of the company's stock worth $1,210,000 after purchasing an additional 21,141 shares during the period. 85.88% of the stock is currently owned by institutional investors and hedge funds.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Articles

Analyst Recommendations for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines